Serological Assays for the Detection and Characterization of Influenza Viruses

Overview
AwardeeAmerican Type Culture Collection
Award ID75D30126C21030
Reported Award$7,335,701
AgencyCenters for Disease Control and Prevention
Award DateMay 18, 2026
PostedMay 18, 2026, 11:22 a.m. EDT
Set AsideNone
NAICS325413 - In-Vitro Diagnostic Substance Manufacturing
PSCQ301 - Reference Laboratory Testing
Place of PerformanceAtlanta, GA United States
Description
Primary

The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay.

Contacts
Contact nameJennifer Gartzke
Contact emailjgartzke@cdc.gov
Contact phoneNone
Same Region Opportunities